ONC releases survey data showing reversal of low interest in EHR adoption in previous years. More than eighty percent of U.S. hospitals, and 41 percent of office-based physicians, intend to take advantage of federal incentive payments for adoption and meaningful use of certified electronic health records (EHR) technology, according to survey ...

ONC releases survey data showing reversal of low interest in EHR adoption in previous years. More than eighty percent of U.S. hospitals, and 41 percent of office-based physicians, intend to take advantage of federal incentive payments for adoption and meaningful use of certified electronic health records (EHR) technology, according to survey ...

ONC releases survey data showing reversal of low interest in EHR adoption in previous years. More than eighty percent of U.S. hospitals, and 41 percent of office-based physicians, intend to take advantage of federal incentive payments for adoption and meaningful use of certified electronic health records (EHR) technology, according to survey ...

ONC releases survey data showing reversal of low interest in EHR adoption in previous years. More than eighty percent of U.S. hospitals, and 41 percent of office-based physicians, intend to take advantage of federal incentive payments for adoption and meaningful use of certified electronic health records (EHR) technology, according to survey ...

ONC releases survey data showing reversal of low interest in EHR adoption in previous years. More than eighty percent of U.S. hospitals, and 41 percent of office-based physicians, intend to take advantage of federal incentive payments for adoption and meaningful use of certified electronic health records (EHR) technology, according to survey ...

Changes will enable researchers to take advantage of advances in molecular oncology. The National Cancer Institute (NCI), a component of the Department of Health & Human Services, announced on Dec. 23 major changes to the Clinical Trials Cooperative Group Program that conducts many of the nationwide trials of new cancer therapies. In a major ...

Changes will enable researchers to take advantage of advances in molecular oncology. The National Cancer Institute (NCI), a component of the Department of Health & Human Services, announced on Dec. 23 major changes to the Clinical Trials Cooperative Group Program that conducts many of the nationwide trials of new cancer therapies. In a major ...

Changes will enable researchers to take advantage of advances in molecular oncology. The National Cancer Institute (NCI), a component of the Department of Health & Human Services, announced on Dec. 23 major changes to the Clinical Trials Cooperative Group Program that conducts many of the nationwide trials of new cancer therapies. In a major ...

Changes will enable researchers to take advantage of advances in molecular oncology. The National Cancer Institute (NCI), a component of the Department of Health & Human Services, announced on Dec. 23 major changes to the Clinical Trials Cooperative Group Program that conducts many of the nationwide trials of new cancer therapies. In a major ...

Changes will enable researchers to take advantage of advances in molecular oncology. The National Cancer Institute (NCI), a component of the Department of Health & Human Services, announced on Dec. 23 major changes to the Clinical Trials Cooperative Group Program that conducts many of the nationwide trials of new cancer therapies. In a major ...